Keri Louise Sturdevant, PA | |
1290 Silas Deane Hwy, Wethersfield, CT 06109-4337 | |
(869) 972-9033 | |
Not Available |
Full Name | Keri Louise Sturdevant |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 12 Years |
Location | 1290 Silas Deane Hwy, Wethersfield, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295094035 | NPI | - | NPPES |
1295094035 | Other | MI | NATIONAL PROVIDER IDENTIFICATION NUMBER |
Facility Name | Location | Facility Type |
---|---|---|
Christus Spohn Hospital Corpus Christi | Corpus christi, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Gulf Coast Intensivists, Pllc | 2264896364 | 35 |
News Archive
Prior to an Alzheimer's diagnosis, a person in the early stages of the disease faces a heightened risk of adverse financial outcomes -; a likely consequence of compromised decision making when managing money, in addition to exploitation and fraud by others.
Diabetes is the number 1 cause of neuropathy, which is a very common condition in itself. In fact, up to half of all neuropathy is caused by diabetes, although other people can get the condition as well.
PipelineRx, a leading clinical telepharmacy platform company supporting medication management, today announced continuing support from the California HealthCare Foundation to help improve quality of care by expanding ways pharmacists can be accessible to more patients in the acute setting.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Keri Louise Sturdevant, PA 16130 Pionciana St, Corpus Christi, TX 78418-6508 Ph: (810) 357-4159 | Keri Louise Sturdevant, PA 1290 Silas Deane Hwy, Wethersfield, CT 06109-4337 Ph: (869) 972-9033 |
News Archive
Prior to an Alzheimer's diagnosis, a person in the early stages of the disease faces a heightened risk of adverse financial outcomes -; a likely consequence of compromised decision making when managing money, in addition to exploitation and fraud by others.
Diabetes is the number 1 cause of neuropathy, which is a very common condition in itself. In fact, up to half of all neuropathy is caused by diabetes, although other people can get the condition as well.
PipelineRx, a leading clinical telepharmacy platform company supporting medication management, today announced continuing support from the California HealthCare Foundation to help improve quality of care by expanding ways pharmacists can be accessible to more patients in the acute setting.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke.
› Verified 3 days ago
Beth Anne Dean, MS, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1025 Silas Deane Hwy Ste 101, Wethersfield, CT 06109 Phone: 877-707-4442 | |
Mrs. Nataliya Krayzman, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 40 Mayfield Rd, Wethersfield, CT 06109 Phone: 860-392-9897 | |
Chelsey Paholski Gavelek, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1290 Silas Deane Hwy, Wethersfield, CT 06109 Phone: 860-972-6977 | |
Shannon Carey, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1260 Silas Deane Hwy, Wethersfield, CT 06109 Phone: 860-258-3470 Fax: 860-571-6800 | |
Nicole L Hettrich, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1025 Silas Deane Hwy, Wethersfield, CT 06109 Phone: 860-696-2400 Fax: 860-696-2410 | |
Alexandra Zhakov, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1260 Silas Deane Hwy, Wethersfield, CT 06109 Phone: 860-258-3477 | |
Christian Keene, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1290 Silas Deane Highway, Hartford Healthcare Cvo, Wethersfield, CT 06109 Phone: 860-972-9093 Fax: 860-972-7040 |